Langbahn Team – Weltmeisterschaft

Reelin: Difference between revisions

Content deleted Content added
References: refs in the scrolling window
per Wikipedia:Citing_sources#Scrolling_lists Undid revision 229243489 by CopperKettle (talk)
Line 246: Line 246:


==References==
==References==
{{Reflist|2}}
<div class="reflist4" style="height: 200px; overflow: auto; padding: 3px" >{{reflist|2}}</div>


[[Category:Molecular neuroscience]]
[[Category:Molecular neuroscience]]

Revision as of 21:45, 1 August 2008

Template:PBB Reelin is a protein found mainly in the brain, but also in the spinal cord, blood and other body organs and tissues. Reelin is crucial for regulating the processes of neuronal migration and positioning in the developing brain. Besides this important role in the early period, reelin continues to work in the adult brain. It modulates the synaptic plasticity by enhancing LTP induction and maintenance.[1][2] It also stimulates dendrite development[3] and regulates the continuing migration of neuroblasts generated in adult neurogenesis sites like subventricular and subgranular zones.

Reelin is implicated in pathogenesis of several brain diseases: significantly lowered expression of the protein have been found in schizophrenia and psychotic bipolar disorder. Total lack of reelin causes a form of lissencephaly; reelin also may play a role in Alzheimer's disease, temporal lobe epilepsy, and autism.

Reelin's name comes from the abnormal reeling gait of reeler mice,[4] which were found to have a deficiency of this brain protein and were homozygous for the RELN gene, which encodes reelin synthesis. The primary phenotype associated with loss of reelin function is inverted cortex, a neuroanatomical defect in which the six cortical layers are inverted. Heterozygous mice for the reelin gene have very little obvious neuroanatomical defect but those that they have resemble the changes of the human schizophrenic brain.


History

Normal and Reeler mice brain slices.

Mutant mice provide insight into the underlying molecular mechanisms of the development of the CNS. These spontaneous mutations were first identified by scientists interested in motor behavior, and it proved relatively easy to screen littermates for mice that showed difficulties moving around the cage. A number of such mice were found and given descriptive names such as reeler, weaver, lurcher, nervous, and staggerer.

The "reeler" mouse was first described in the 1951 edition of Journal of Genetics by Douglas Scott Falconer.[4] Histopathological studies in the 1960's revealed that the reeler cerebellum is dramatically decreased in size and the normal laminar organization found in several brain regions is disrupted.[5] 1970's brought the discovery of cellular layers inversion in the mice neocortex[6], which attracted more attention to the reeler mutation.

In 1995, the RELN gene and protein were discovered at chromosome 7q22 by Gabriella D'Arcangelo and colleagues[7]. Almost immediately, Japanese scientists at Kochi Medical School had successfully created the first monoclonal antibody for reelin, called CR-50.[8] They noted that CR-50 reacted specifically with Cajal-Retzius neurons, whose functional role was unknown till then.

The downstream pathway of Reelin was clarified using other mutant mice, including yotari and scrambler. These mice have phenotypes similar to that of reeler but have no mutation in reelin. It was then demonstrated that the mouse disabled homologue 1 (Dab1) gene, which encodes a homolog of Drosophila disabled, is the gene responsible for the phenotypes of these mutant mice, and Dab1 protein was absent (yotari) or only barely (scrambler) detectable in these mutants.[9] Targeted disruption of Dab1 also caused a phenotype similar to that of reeler.

The Reelin receptors, apolipoprotein E receptor 2 and very-low-density lipoprotein receptor, were discovered serendipitously by Trommsdorff et al, who found that the double knockout mice for apolipoprotein E receptor 2 and very-low-density lipoprotein receptor, which they generated for another experiment, showed defects in cortical layering similar to that in reeler.[10]

In the July of 2006, a group of Japanese scientists published the first report of X-ray crystallography and electron tomography investigation of reelin structure.[11]

Secretion and localization of reelin

wild-type mouse cortex
Reeler cortex

Studies show that Reelin is absent from synaptic vesicles and is secreted via constitutive secretory pathway, being stored in Golgi secretory vesicles.[12] Reelin's release rate is not regulated by depolarization, but strictly depends on its synthesis rate. This relationship is similar to that reported for the secretion of other ECM proteins.

In the cortex and hippocampus, reelin is secreted by Cajal-Retzius cells, Cajal cells, and Retzius cells during brain development.[13] In the cerebellum, Reelin is expressed first in the external granule cell layer (EGL) before the granule cell migration to the internal granule cell layer (IGL)[14]. In the adult brain, Reelin is expressed by GABA-ergic interneurons of the cortex and glutamatergic cerebellar neurons.[15] Among GABAergic interneurons, Reelin seems to be detected predominantly in those expressing calretinin and calbindin, like bitufted, horizontal, and Martinotti cells, but not parvalbumin-expressing cells, like chandelier or basket neurons.[16][17] Outside the brain, reelin is found in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells. [18] In the liver, reelin is localized in hepatic stellate cells.[19] Its expression goes up when the liver is damaged, and returns to normal following its repair. [20]

Schema of the Reelin protein

Structure

Reelin is a secreted extracellular matrix glycoprotein composed of 3461 amino acids with a relative molecular mass of 388 kDa.

Reelin molecule starts with a signaling peptide 27 amino acids in length, followed by a region bearing similarity to F-spondin, marked as "SP" on the scheme, and by a region unique to reelin, marked as "H". Next come the 8 repeats of 300-350 amino acids. These are called reelin repeats and have an EGF motif at their center, dividing each repeat into two subrepeats, A and B. Despite this interruption, the two subdomains make direct contact, resulting in a compact overall structure.[11]

The last comes a highly basic and short C-terminal region (CTR, marked "+") with a length of 32 amino acids. This region is extremely conservative, being 100% identical in all investigated mammals. It was thought that CTR is necessary for reelin secretion, because Orleans reeler mutation, which lacks a part of 8th repeat and the whole CTR, is unable to secrete the misshaped protein, leading to its concentration in cytoplasm. However, one recent study has shown that the CTR is not essential for secretion, which is most probably hindered then reelin is cut along one of the repeats.[21]

Reelin is cleaved in vivo at two sites located after domains 2 and 6 - approximately between repeats 2 and 3 and between repeats 6 and 7, resulting in the production of three fragments.[22] This splitting does not decrease the protein's activity, as constructs made of the predicted central fragments (repeats 3–6) bind to lipoprotein receptors, trigger Dab1 phosphorylation and mimic functions of reelin during cortical plate development.[23]

Function and mechanism of action

In the process of neural development, Reelin acts on migrating neuronal precursors and controls correct cell positioning in the cortex and other brain structures. The proposed role is one of a dissociation signal for neuronal groups, allowing them to separate and go from tangential chain-migration to radial individual migration.[24] Dissociation detaches migrating neurons from the glial cells that are acting as their guides, converting them into individual cells that can strike out alone to find their final position.

In the adult brain, Reelin plays an important role by modulating cortical pyramidal neuron dendritic spine expression density, the branching of dendrites, and the expression of long-term potentiation.

Mechanism of action

Reelin acts on two receptors:

  • VLDLR (very-low-density lipoprotein receptor) and the
  • ApoER2 (apolipoprotein E receptor 2),

which are members of the Low density lipoprotein receptor gene family.

The intracellular adaptor DAB1 binds to the VLDLR and ApoER2 through an NPxY motif and is involved in transmission of Reelin signals through these lipoprotein receptors.

The proposal that the protocadherin CNR1 behaves as a Reelin receptor[25] has been disproved.[23]

It has been shown that alpha-3-beta-1 integrin binds to the N-terminal region of reelin, a site distinct from the region of reelin shown to associate with other reelin receptors such as VLDLR/ApoER2.[26]

Reelin molecules have been shown[27] [28] to form a large protein complex, a disulfide-linked homodimer. If the homodimer fails to form, efficient tyrosine phosphorylation of DAB1 also fails.

Reelin-dependent strengthening of long-term potentiation is caused by ApoER2 interaction with NMDA receptor. This interaction happens when ApoER2 has a region coded by exon 19. ApoER2 gene is alternatively spliced, with the exon 19-containing variant more actively produced during periods of activity.[29]

Role in brain pathology

Lissencephaly

Disruptions of the RELN gene are condsidered to be the cause of the rare form of lissencephaly with cerebellar hypoplasia called Norman-Roberts syndrome.[30][31] The mutations disrupt splicing of RELN cDNA, resulting in low or undetectable amounts of reelin protein. The phenotype in these patients was characterized by hypotonia, ataxia, and developmental delay, with lack of unsupported sitting and profound mental retardation with little or no language development. Seizures and congenital lymphedema were also present.

Reduced expression of reelin and its mRNA levels in the brains of schizophrenia sufferers had been reported in 1998[32] and 2000[33] and independently confirmed in the postmortem studies of hippocampus samples[34] and in the cortex studies.[35][36] The reduction may reach up to 50% in some brain regions and is coupled with reduced expression of GAD-67 enzyme,[37] which catalyses the transition of glutamate to GABA. Blood levels of reelin and its isoforms are also altered in schizophrenia, along with other mood disorders, according to one study.[38] Reduced reelin mRNA prefrontal expression in schizophrenia was found to be the most statistically relevant disturbance found in the multicenter study conducted in 14 separate laboratories in 2001 by Stanley Foundation Neuropathology Consortium.[39]

Epigenetic hypermethylation of DNA in schizophrenia patients is proposed as a cause of the reduction,[40][41] in accordance with the knowledge that administration of methionine to schizophrenic patients results in a profound exacerbation of schizophrenia symptoms in sixty to seventy percent of patients, a fact discovered in the 1960's.[42][43][44][45] In contrast with initial data, subsequent studies failed to confirm the hypermethylation.[46][47] A postmortem study comparing DNMT1 and Reelin mRNA expression in cortical layers I and V of schizophrenic patients and normal controls demonstrated that in the layer V both DNMT1 and Reelin levels were normal, while in the layer I DNMT1 was threefold higher, probably leading to the twofold decrease in the Reelin expression. [48] Methylation inhibitors and histone deacetylase inhibitors, such as valproic acid, increase reelin mRNA levels,[49] [50] [51] while L-methionine treatment downregulates the phenotypic expression of reelin. [52]

Heterozygous reeler mouse, which is haploinsufficient for the reeler gene, shares several neurochemical and behavioral abnormalities with schizophrenia and bipolar disorder[53], but considered as not suitable for use as a genetic mouse model of schizophrenia.[54]

Bipolar disorder

Decrease in RELN expression is typical of bipolar disorder with psychosis, but is not characteristic of patients with major depression without psychosis.[33]

A number of studies have shown an association between the reelin gene and autism[55] [56]. A couple of studies were unable to duplicate linkage findings, however.[57][58]

Temporal Lobe Epilepsy

Decreased reelin expression in the hippocampal tissue samples from patients with temporal lobe epilepsy was found to be directly correlated to the extent of granule cell dispersion, a major feature of the disease.[59] [60] According to one study, prolonged seizures in a rat model of mesial temporal lobe epilepsy have led to the loss of reelin-expressing interneurons and subsequent ectopic chain migration and aberrant integration of newborn dentate granule cells. Without reelin, the chain-migrating neuroblasts failed to detach properly.[61]

According to one study, reelin expression and glycosylation patterns are altered in Alzheimer's disease. In the cortex of the patients, reelin levels were 40% higher compared with controls, but the cerebellar levels of the protein remain normal in the same patients.[62] This finding correlates with an earlier study showing the presence of Reelin associated with amyloid plaques in a transgenic AD mouse model. [63]

  1. Förster E, Jossin Y, Zhao S, Chai X, Frotscher M, Goffinet AM (2006). "Recent progress in understanding the role of Reelin in radial neuronal migration, with specific emphasis on the dentate gyrus". Eur. J. Neurosci. 23 (4): 901–9. doi:10.1111/j.1460-9568.2006.04612.x. PMID 16519655. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

Articles, publications, webpages

Figures and images

References

  1. ^ Weeber EJ, Beffert U, Jones C; et al. (2002). "Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning". J. Biol. Chem. 277 (42): 39944–52. doi:10.1074/jbc.M205147200. PMID 12167620. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)W
  2. ^ D'Arcangelo G (2005). "Apoer2: a reelin receptor to remember". Neuron. 47 (4): 471–3. doi:10.1016/j.neuron.2005.08.001. PMID 16102527. {{cite journal}}: Unknown parameter |month= ignored (help)
  3. ^ Niu S, Renfro A, Quattrocchi CC, Sheldon M, D'Arcangelo G (2004). "Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway". Neuron. 41 (1): 71–84. PMID 14715136. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  4. ^ a b Falconer DS (1951) 2 new mutants, trembler and reeler, with neurological actions in the house mouse (mus-musculus l) Journal of Genetics 50 (2): 192-201 [1]
  5. ^ Hamburgh M (1963). "Analysis of the postnatal developmental effects of "reeler", a neurological mutation in mice. A study in developmental genetics". Dev. Biol. 19: 165–85. PMID 14069672. {{cite journal}}: Unknown parameter |month= ignored (help)
  6. ^ Caviness VS (1976). "Patterns of cell and fiber distribution in the neocortex of the reeler mutant mouse". J. Comp. Neurol. 170 (4): 435–47. doi:10.1002/cne.901700404. PMID 1002868. {{cite journal}}: Unknown parameter |month= ignored (help)
  7. ^ D'Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T (1995). "A protein related to extracellular matrix proteins deleted in the mouse mutant reeler". Nature. 374 (6524): 719–23. doi:10.1038/374719a0. PMID 7715726. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  8. ^ Ogawa M, Miyata T, Nakajima K; et al. (1995). "The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons". Neuron. 14 (5): 899–912. PMID 7748558. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  9. ^ Sheldon M, Rice DS, D'Arcangelo G; et al. (1997). "Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice". Nature. 389 (6652): 730–3. doi:10.1038/39601. PMID 9338784. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  10. ^ Trommsdorff M, Gotthardt M, Hiesberger T; et al. (1999). "Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2". Cell. 97 (6): 689–701. PMID 10380922. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  11. ^ a b Nogi T, Yasui N, Hattori M, Iwasaki K, Takagi J (2006). "Structure of a signaling-competent reelin fragment revealed by X-ray crystallography and electron tomography". EMBO J. 25 (15): 3675–83. doi:10.1038/sj.emboj.7601240. PMC 1538547. PMID 16858396. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  12. ^ Lacor PN, Grayson DR, Auta J, Sugaya I, Costa E, Guidotti A (2000). "Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation". Proc. Natl. Acad. Sci. U.S.A. 97 (7): 3556–61. doi:10.1073/pnas.050589597. PMC 16278. PMID 10725375. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  13. ^ Meyer G, Goffinet AM, Fairén A (1999). "What is a Cajal-Retzius cell? A reassessment of a classical cell type based on recent observations in the developing neocortex". Cereb. Cortex. 9 (8): 765–75. PMID 10600995. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  14. ^ Schiffmann SN, Bernier B, Goffinet AM (1997). "Reelin mRNA expression during mouse brain development". Eur. J. Neurosci. 9 (5): 1055–71. PMID 9182958. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  15. ^ Pesold C, Impagnatiello F, Pisu MG; et al. (1998). "Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats". Proc. Natl. Acad. Sci. U.S.A. 95 (6): 3221–6. PMC 19723. PMID 9501244. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  16. ^ Alcántara S, Ruiz M, D'Arcangelo G; et al. (1998). "Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse". J. Neurosci. 18 (19): 7779–99. PMID 9742148. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  17. ^ Pesold C, Liu WS, Guidotti A, Costa E, Caruncho HJ (1999). "Cortical bitufted, horizontal, and Martinotti cells preferentially express and secrete reelin into perineuronal nets, nonsynaptically modulating gene expression". Proc. Natl. Acad. Sci. U.S.A. 96 (6): 3217–22. PMC 15922. PMID 10077664. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  18. ^ Smalheiser NR, Costa E, Guidotti A; et al. (2000). "Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells". Proc. Natl. Acad. Sci. U.S.A. 97 (3): 1281–6. PMC 15597. PMID 10655522. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  19. ^ Samama B, Boehm N (2005). "Reelin immunoreactivity in lymphatics and liver during development and adult life". Anat Rec a Discov Mol Cell Evol Biol. 285 (1): 595–9. doi:10.1002/ar.a.20202. PMID 15912522. {{cite journal}}: Unknown parameter |month= ignored (help)
  20. ^ Kobold D, Grundmann A, Piscaglia F; et al. (2002). "Expression of reelin in hepatic stellate cells and during hepatic tissue repair: a novel marker for the differentiation of HSC from other liver myofibroblasts". J. Hepatol. 36 (5): 607–13. PMID 11983443. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  21. ^ Nakano Y, Kohno T, Hibi T; et al. (2007). "The extremely conserved C-terminal region of Reelin is not necessary for secretion but is required for efficient activation of downstream signaling". J. Biol. Chem. 282 (28): 20544–52. doi:10.1074/jbc.M702300200. PMID 17504759. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
  22. ^ Lambert de Rouvroit C, de Bergeyck V, Cortvrindt C, Bar I, Eeckhout Y, Goffinet AM (1999). "Reelin, the extracellular matrix protein deficient in reeler mutant mice, is processed by a metalloproteinase". Exp. Neurol. 156 (1): 214–7. doi:10.1006/exnr.1998.7007. PMID 10192793. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  23. ^ a b Jossin Y, Ignatova N, Hiesberger T, Herz J, Lambert de Rouvroit C, Goffinet AM (2004). "The central fragment of Reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development". J. Neurosci. 24 (2): 514–21. doi:10.1523/JNEUROSCI.3408-03.2004. PMID 14724251. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  24. ^ Hack I, Bancila M, Loulier K, Carroll P, Cremer H (2002). "Reelin is a detachment signal in tangential chain-migration during postnatal neurogenesis". Nat. Neurosci. 5 (10): 939–45. doi:10.1038/nn923. PMID 12244323. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  25. ^ Senzaki K, Ogawa M, Yagi T (1999). "Proteins of the CNR family are multiple receptors for Reelin". Cell. 99 (6): 635–47. PMID 10612399. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  26. ^ Schmid RS, Jo R, Shelton S, Kreidberg JA, Anton ES (2005). "Reelin, integrin and DAB1 interactions during embryonic cerebral cortical development". Cereb. Cortex. 15 (10): 1632–6. doi:10.1093/cercor/bhi041. PMID 15703255. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  27. ^ Utsunomiya-Tate N, Kubo K, Tate S; et al. (2000). "Reelin molecules assemble together to form a large protein complex, which is inhibited by the function-blocking CR-50 antibody". Proc. Natl. Acad. Sci. U.S.A. 97 (17): 9729–34. doi:10.1073/pnas.160272497. PMC 16933. PMID 10920200. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  28. ^ Kubo K, Mikoshiba K, Nakajima K (2002). "Secreted Reelin molecules form homodimers". Neurosci. Res. 43 (4): 381–8. PMID 12135781. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  29. ^ Beffert U, Weeber EJ, Durudas A; et al. (2005). "Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2" (PDF). Neuron. 47 (4): 567–79. doi:10.1016/j.neuron.2005.07.007. PMID 16102539. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  30. ^ a b c Hong SE, Shugart YY, Huang DT; et al. (2000). "Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations". Nat. Genet. 26 (1): 93–6. doi:10.1038/79246. PMID 10973257. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  31. ^ Crino P (2001). "New RELN Mutation Associated with Lissencephaly and Epilepsy". Epilepsy Curr. 1 (2): 72. doi:10.1046/j.1535-7597.2001.00017.x. PMC 320825. PMID 15309195. {{cite journal}}: Unknown parameter |month= ignored (help)
  32. ^ Impagnatiello F, Guidotti AR, Pesold C; et al. (1998). "A decrease of reelin expression as a putative vulnerability factor in schizophrenia". Proc. Natl. Acad. Sci. U.S.A. 95 (26): 15718–23. PMC 28110. PMID 9861036. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  33. ^ a b Guidotti A, Auta J, Davis JM; et al. (2000). "Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study". Arch. Gen. Psychiatry. 57 (11): 1061–9. PMID 11074872. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  34. ^ Fatemi SH, Earle JA, McMenomy T (2000). "Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression". Mol. Psychiatry. 5 (6): 654–63, 571. PMID 11126396. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  35. ^ Eastwood SL, Harrison PJ (2003). "Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis". Mol. Psychiatry. 8 (9): 769, 821–31. doi:10.1038/sj.mp.4001371. PMID 12931209. {{cite journal}}: Unknown parameter |month= ignored (help)
  36. ^ Abdolmaleky HM, Cheng KH, Russo A; et al. (2005). "Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report". Am. J. Med. Genet. B Neuropsychiatr. Genet. 134B (1): 60–6. doi:10.1002/ajmg.b.30140. PMID 15717292. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  37. ^ Fatemi SH, Hossein Fatemi S, Stary JM, Earle JA, Araghi-Niknam M, Eagan E (2005). "GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum". Schizophr. Res. 72 (2–3): 109–22. doi:10.1016/j.schres.2004.02.017. PMID 15560956. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  38. ^ Fatemi SH, Kroll JL, Stary JM (2001). "Altered levels of Reelin and its isoforms in schizophrenia and mood disorders". Neuroreport. 12 (15): 3209–15. PMID 11711858. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  39. ^ Knable MB, Torrey EF, Webster MJ, Bartko JJ (2001). "Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium". Brain Res. Bull. 55 (5): 651–9. PMID 11576762. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  40. ^ Grayson DR, Jia X, Chen Y; et al. (2005). "Reelin promoter hypermethylation in schizophrenia". Proc. Natl. Acad. Sci. U.S.A. 102 (26): 9341–6. doi:10.1073/pnas.0503736102. PMC 1166626. PMID 15961543. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  41. ^ a b Dong E, Agis-Balboa RC, Simonini MV, Grayson DR, Costa E, Guidotti A (2005). "Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia". Proc. Natl. Acad. Sci. U.S.A. 102 (35): 12578–83. doi:10.1073/pnas.0505394102. PMC 1194936. PMID 16113080. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  42. ^ Pollin W, Cardon PV, Kety SS (1961). "Effects of amino acid feedings in schizophrenic patients treated with iproniazid". Science (journal). 133: 104–5. PMID 13736870. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  43. ^ Brune GG, Himwich HE (1962). "Effects of methionine loading on the behavior of schizophrenic patients". J. Nerv. Ment. Dis. 134: 447–50. PMID 13873983. {{cite journal}}: Unknown parameter |month= ignored (help)
  44. ^ Park L, Baldessarini RJ, Kety SS (1965). "Effects of methionine ingestion in chronic schizophrenia patients treated with monoamine oxidase inhibitors". Arch. Gen. Psychiatry. 12: 346–51. PMID 14258360. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  45. ^ Antun FT, Burnett GB, Cooper AJ, Daly RJ, Smythies JR, Zealley AK (1971). "The effects of L-methionine (without MAOI) in schizophrenia". J Psychiatr Res. 8 (2): 63–71. PMID 4932991. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  46. ^ Tochigi M, Iwamoto K, Bundo M, Komori A, Sasaki T, Kato N, Kato T (2007). "Methylation Status of the Reelin Promoter Region in the Brain of Schizophrenic Patients". Biological Psychiatry. 63: 530. doi:10.1016/j.biopsych.2007.07.003. PMID 17870056.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  47. ^ Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, Jia P, Assadzadeh A, Flanagan J, Schumacher A, Wang SC, Petronis A (2008). "Epigenomic profiling reveals DNA-methylation changes associated with major psychosis". Am. J. Hum. Genet. 82 (3): 696–711. doi:10.1016/j.ajhg.2008.01.008. PMID 18319075.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  48. ^ Ruzicka WB, Zhubi A, Veldic M, Grayson DR, Costa E, Guidotti A (2007). "Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection". Mol. Psychiatry. 12 (4): 385–97. doi:10.1038/sj.mp.4001954. PMID 17264840. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  49. ^ Tremolizzo L, Doueiri MS, Dong E; et al. (2005). "Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice". Biol. Psychiatry. 57 (5): 500–9. doi:10.1016/j.biopsych.2004.11.046. PMID 15737665. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  50. ^ Chen Y, Sharma RP, Costa RH, Costa E, Grayson DR (2002). "On the epigenetic regulation of the human reelin promoter". Nucleic Acids Res. 30 (13): 2930–9. PMC 117056. PMID 12087179. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  51. ^ Mitchell CP, Chen Y, Kundakovic M, Costa E, Grayson DR (2005). "Histone deacetylase inhibitors decrease reelin promoter methylation in vitro". J. Neurochem. 93 (2): 483–92. doi:10.1111/j.1471-4159.2005.03040.x. PMID 15816871. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  52. ^ Tremolizzo L, Carboni G, Ruzicka WB; et al. (2002). "An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 17095–100. doi:10.1073/pnas.262658999. PMC 139275. PMID 12481028. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  53. ^ Pappas GD, Kriho V, Pesold C (2001). "Reelin in the extracellular matrix and dendritic spines of the cortex and hippocampus: a comparison between wild type and heterozygous reeler mice by immunoelectron microscopy" (PDF). J. Neurocytol. 30 (5): 413–25. PMID 11951052. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  54. ^ Podhorna J, Didriksen M (2004). "The heterozygous reeler mouse: behavioural phenotype". Behav. Brain Res. 153 (1): 43–54. doi:10.1016/j.bbr.2003.10.033. PMID 15219705. {{cite journal}}: Unknown parameter |month= ignored (help)
  55. ^ Serajee FJ, Zhong H, Mahbubul Huq AH (2006). "Association of Reelin gene polymorphisms with autism". Genomics. 87 (1): 75–83. doi:10.1016/j.ygeno.2005.09.008. PMID 16311013. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  56. ^ Skaar DA, Shao Y, Haines JL; et al. (2005). "Analysis of the RELN gene as a genetic risk factor for autism". Mol. Psychiatry. 10 (6): 563–71. doi:10.1038/sj.mp.4001614. PMID 15558079. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  57. ^ Devlin B, Bennett P, Dawson G; et al. (2004). "Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the CPEA network". Am. J. Med. Genet. B Neuropsychiatr. Genet. 126B (1): 46–50. doi:10.1002/ajmg.b.20125. PMID 15048647. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  58. ^ Li J, Nguyen L, Gleason C; et al. (2004). "Lack of evidence for an association between WNT2 and RELN polymorphisms and autism". Am. J. Med. Genet. B Neuropsychiatr. Genet. 126B (1): 51–7. doi:10.1002/ajmg.b.20122. PMID 15048648. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  59. ^ Haas CA, Dudeck O, Kirsch M; et al. (2002). "Role for reelin in the development of granule cell dispersion in temporal lobe epilepsy". J. Neurosci. 22 (14): 5797–802. doi:20026621. PMID 12122039. {{cite journal}}: Check |doi= value (help); Explicit use of et al. in: |author= (help); Unknown parameter |doi_brokendate= ignored (|doi-broken-date= suggested) (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  60. ^ Heinrich C, Nitta N, Flubacher A; et al. (2006). "Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus". J. Neurosci. 26 (17): 4701–13. doi:10.1523/JNEUROSCI.5516-05.2006. PMID 16641251. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  61. ^ Gong C, Wang TW, Huang HS, Parent JM (2007). "Reelin regulates neuronal progenitor migration in intact and epileptic hippocampus". J. Neurosci. 27 (8): 1803–11. doi:10.1523/JNEUROSCI.3111-06.2007. PMID 17314278. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  62. ^ Botella-López A, Burgaya F, Gavín R; et al. (2006). "Reelin expression and glycosylation patterns are altered in Alzheimer's disease". Proc. Natl. Acad. Sci. U.S.A. 103 (14): 5573–8. doi:10.1073/pnas.0601279103. PMC 1414634. PMID 16567613. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  63. ^ Wirths O, Multhaup G, Czech C; et al. (2001). "Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice". Neurosci. Lett. 316 (3): 145–8. PMID 11744223. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)


Template:PBB Controls